ArticleThe AAPS journal2018

Risk-Based Comparability Assessment for Monoclonal Antibodies During Drug Development: A Clinical Pharmacology Perspective.

Yanli Zhuang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.